SING IMT (mini telescope for vision recovery)

2024: Product Announcement

At the end of July 2024, it became known that the Chinese doctor Li Xiaorong performed the first operation using the SING IMT miniature telescope manufactured by the Samsara Vision team to correct the consequences of central blindness in a patient with late-stage age-related macular degeneration. The operation was performed at the Lecheng Hospital of Hainan Medical University and was successful.

Central blindness caused by late-stage age-related macular degeneration is a scourge of many older adults that significantly reduces quality of life. To correct this condition, Samsara Vision has developed the SING IMT implantable mini telescope with a new foldable design that stabilizes and centers the implant during surgery. In addition, the company has developed a new delivery system, Tsert SI, that should reduce the length of the surgical procedure, the size of the incision and the number of stitches, speeding up postoperative recovery. Samsara Vision claims the device helps patients see objects at all distances, still and moving. Users can also perform a number of activities similar to natural vision capabilities.

Samsara Vision

We are rapidly developing a global network of providers, researchers and physicians who are helping patients with irreversible central blindness caused by macular degeneration become familiar with our new technology, "explained Thomas Ruggia, President and CEO of Samsara Vision. - Our goal is for SING IMT to become the standard of care for people with advanced stage of a given disease. We congratulate Professor Lee and thank our partners at Lensheng Medical who are helping our company advance in the Chinese market.[1]

Notes